Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 15;7(12):2805-14.
eCollection 2015.

BAG3 regulates ECM accumulation in renal proximal tubular cells induced by TGF-β1

Affiliations

BAG3 regulates ECM accumulation in renal proximal tubular cells induced by TGF-β1

Feng Du et al. Am J Transl Res. .

Abstract

Previously we have demonstrated that Bcl-2-associated athanogene 3 (BAG3) is increased in renal fibrosis using a rat unilateral ureteral obstruction model. The current study investigated the role of BAG3 in renal fibrosis using transforming growth factor (TGF)-β1-treated human proximal tubular epithelial (HK-2) cells. An upregulation of BAG3 in vitro models was observed, which correlated with the increased synthesis of extracellular matrix (ECM) proteins and expression of tissue-type plasminogen activator inhibitor (PAI)-1. Blockade of BAG3 induction by shorting hairpin RNA suppressed the expression of ECM proteins but had no effect on PAI-1 expression induced by TGF-β1. Forced overexpression of BAG3 selectively increased collagens. TGF-β1-induced BAG3 expression in HK-2 cells was attenuated by ERK1/2 and JNK MAPK inhibitors. In addition, forced BAG3 overexpression blocked attenuation of collagens expression by ERK1/2 and JNK inhibitors. These data suggest that ERK1/2 and JNK signaling events are involved in modulating the expression of BAG3, which would ultimately contribute to renal fibrosis by enhancing the synthesis and deposition of ECM proteins.

Keywords: BAG3; ECM; MAPK; tubular epithelial cell.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Induction of BAG3, Col I, Col IV, FN, and PAI-1 by TGF-β1 in HK2 cells. A. HK2 cells were treated with indicated dose of TGF-β1 for 24 h, mRNA levels of BAG3, Col I, Col IV, FN, and PAI-1 were measured by real time RT-PCR. B. HK2 cells were treated with 10 ng/ml TGF-β1 for indicated time, mRNA levels of BAG3, Col I, Col IV, FN, and PAI-1 were measured by real time RT-PCR. C. HK2 cells were treated with indicated dose of TGF-β1 for 24 h, western blot analysis was performed using the indicated antibodies. D. HK2 cells were treated with 10 ng/ml TGF-β1 for indicated time, western blot analysis was performed using the indicated antibodies. E. HK2 cells were treated with indicated dose of TGF-β1 for 24 h, culture supernatants were collected and dot blot was performed using the indicated antibodies. F. HK2 cells were treated with 10 ng/ml TGF-β1 for indicated time. After that, supernatant was collected and dot blot was performed using the indicated antibodies. *, P<0.01.
Figure 2
Figure 2
Attenuation of TGF-β1 mediated accumulation of ECM proteins by BAG3 knockdown. A. HK2 cells were infected with shBAG3 or scramble lentiviral vectors for 12 h and cultured for additional 48 h. Cells were then treated with 10 ng/ml of TGF-β1 for additional 24 h. BAG3 and ECM proteins mRNA expression was analyzed using real-time RT-PCR. B. HK2 cells were transduced with shBAG3 or scramble lentiviral vectors for 12 h and cultured for additional 48 h. Cells were then treated with 10 ng/ml of TGF-β1 for additional 24 h and Western blot was performed using the indicated antibodies. C. HK2 cells were infected with shBAG3 or scramble lentiviral vectors for 12 h and cultured for additional 48 h. Cells were then treated with 10 ng/ml of TGF-β1 for additional 24 h. Culture supernatants were collected and dot blot was performed using the indicated antibodies.
Figure 3
Figure 3
Selective induction of collagens generation by overexpression of BAG3. A. HK2 cells were infected with lentiviral vectors containing empty or BAG3 construct for 12 h and cultured for additional 48 h. mRNA levels of BAG3 and ECM proteins were analyzed using real-time RT-PCR. B. HK2 cells were infected with lentiviral vectors containing empty or BAG3 construct for 12 h and cultured for additional 48 h, Western blot was performed using the indicated antibodies. C. HK2 cells were infected with lentiviral vectors containing empty or BAG3 construct for 12 h and cultured for additional 48 h. Culture supernatants were collected and dot blot was performed using the indicated antibodies. D. HK2 cells were infected with lentiviral vectors containing empty or BAG3 construct, viable cells were counted daily.
Figure 4
Figure 4
Implication of JNK and ERK1/2 signaling pathways in induction of BAG3 expression by TGF-β1. A. HK2 cells were individually pretreated with the JNK inhibitor SP600125, p38 inhibitor SB203580, or the ERK1/2 inhibitor PD98059 for 60 min before treatment with TGF-β1. mRNA levels of BAG3 was measured by real time RT-PCR. B. HK2 cells were individually pretreated with the JNK inhibitor SP600125, p38 inhibitor SB203580, or the ERK1/2 inhibitor PD98059 for 60 min before treatment with TGF-β1. Western blot was performed using the indicated antibodies. C. HK2 cells were individually pretreated with the JNK inhibitor SP600125, p38 inhibitor SB203580, or the ERK1/2 inhibitor PD98059 for 60 min before treatment with TGF-β1. Culture supernatants were collected and dot blot was performed using the indicated antibodies.
Figure 5
Figure 5
Attenuation of suppressive effects of ERK1/2 and JNK inhibition on ECM accumulation mediated by TGF-β1. A. HK2 cells infected with lentivirus containing empty or BAG3 constructed vectors were pretreated with SP600125 or PD98059 for 60 min individually before treatment with TGF-β1. mRNA levels of BAG3 and ECM proteins were evaluated using real time RT-PCR. B. HK2 cells infected with lentivirus containing empty or BAG3 constructed vectors were pretreated with SP600125 or PD98059 for 60 min individually before treatment with TGF-β1. Western blot was performed using the indicated antibodies. C. HK2 cells infected with lentivirus containing empty or BAG3 constructed vectors were pretreated with SP600125 or PD98059 for 60 min individually before treatment with TGF-β1. Supernatants were collected and dot blot was performed using the indicated antibodies.

References

    1. Hewitson TD. Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol. 2009;296:F1239–1244. - PubMed
    1. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, Blum JS, Bredesen DE, Brodsky JL, Brumell JH, Brunk UT, Bursch W, Camougrand N, Cebollero E, Cecconi F, Chen Y, Chin LS, Choi A, Chu CT, Chung J, Clarke PG, Clark RS, Clarke SG, Clave C, Cleveland JL, Codogno P, Colombo MI, Coto-Montes A, Cregg JM, Cuervo AM, Debnath J, Demarchi F, Dennis PB, Dennis PA, Deretic V, Devenish RJ, Di Sano F, Dice JF, Difiglia M, Dinesh-Kumar S, Distelhorst CW, Djavaheri-Mergny M, Dorsey FC, Droge W, Dron M, Dunn WA Jr, Duszenko M, Eissa NT, Elazar Z, Esclatine A, Eskelinen EL, Fesus L, Finley KD, Fuentes JM, Fueyo J, Fujisaki K, Galliot B, Gao FB, Gewirtz DA, Gibson SB, Gohla A, Goldberg AL, Gonzalez R, Gonzalez-Estevez C, Gorski S, Gottlieb RA, Haussinger D, He YW, Heidenreich K, Hill JA, Hoyer-Hansen M, Hu X, Huang WP, Iwasaki A, Jaattela M, Jackson WT, Jiang X, Jin S, Johansen T, Jung JU, Kadowaki M, Kang C, Kelekar A, Kessel DH, Kiel JA, Kim HP, Kimchi A, Kinsella TJ, Kiselyov K, Kitamoto K, Knecht E, Komatsu M, Kominami E, Kondo S, Kovacs AL, Kroemer G, Kuan CY, Kumar R, Kundu M, Landry J, Laporte M, Le W, Lei HY, Lenardo MJ, Levine B, Lieberman A, Lim KL, Lin FC, Liou W, Liu LF, Lopez-Berestein G, Lopez-Otin C, Lu B, Macleod KF, Malorni W, Martinet W, Matsuoka K, Mautner J, Meijer AJ, Melendez A, Michels P, Miotto G, Mistiaen WP, Mizushima N, Mograbi B, Monastyrska I, Moore MN, Moreira PI, Moriyasu Y, Motyl T, Munz C, Murphy LO, Naqvi NI, Neufeld TP, Nishino I, Nixon RA, Noda T, Nurnberg B, Ogawa M, Oleinick NL, Olsen LJ, Ozpolat B, Paglin S, Palmer GE, Papassideri I, Parkes M, Perlmutter DH, Perry G, Piacentini M, Pinkas-Kramarski R, Prescott M, Proikas-Cezanne T, Raben N, Rami A, Reggiori F, Rohrer B, Rubinsztein DC, Ryan KM, Sadoshima J, Sakagami H, Sakai Y, Sandri M, Sasakawa C, Sass M, Schneider C, Seglen PO, Seleverstov O, Settleman J, Shacka JJ, Shapiro IM, Sibirny A, Silva-Zacarin EC, Simon HU, Simone C, Simonsen A, Smith MA, Spanel-Borowski K, Srinivas V, Steeves M, Stenmark H, Stromhaug PE, Subauste CS, Sugimoto S, Sulzer D, Suzuki T, Swanson MS, Tabas I, Takeshita F, Talbot NJ, Talloczy Z, Tanaka K, Tanaka K, Tanida I, Taylor GS, Taylor JP, Terman A, Tettamanti G, Thompson CB, Thumm M, Tolkovsky AM, Tooze SA, Truant R, Tumanovska LV, Uchiyama Y, Ueno T, Uzcategui NL, van der Klei I, Vaquero EC, Vellai T, Vogel MW, Wang HG, Webster P, Wiley JW, Xi Z, Xiao G, Yahalom J, Yang JM, Yap G, Yin XM, Yoshimori T, Yu L, Yue Z, Yuzaki M, Zabirnyk O, Zheng X, Zhu X, Deter RL. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008;4:151–175. - PMC - PubMed
    1. Razzaque MS, Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Electron Microsc. 2002;35:68–80. - PubMed
    1. Huang Y, Noble NA. PAI-1 as a target in kidney disease. Curr Drug Targets. 2007;8:1007–1015. - PubMed
    1. Botta A, Delteil F, Mettouchi A, Vieira A, Estrach S, Negroni L, Stefani C, Lemichez E, Meneguzzi G, Gagnoux-Palacios L. Confluence switch signaling regulates ECM composition and the plasmin proteolytic cascade in keratinocytes. J Cell Sci. 2012;125:4241–4252. - PubMed

LinkOut - more resources